16.200
+0,62%
2026-10-19
Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +76.4% | +189.4% | 2 / 3 | +13.1% | +4.02 pp | +2.25 pp | +23.2% | 0.00 | 4.05 | 129 | +13,1% | 8,1 | +76,4% | 4.05 | 10.17 | −60,2% |
| Pts | 12 | 12 | 8 | 4 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 16.200 (close price on 2026-10-19)EPS (TTM): 4.000
Financial charts
1.Revenue & growth
VND bn129Q2/26
1.Revenue & growth
VND bn129Q2/26
2.Profit & growth
VND bn8,37Q2/26
3.Profit mix (Penman)
VND bn61,0Q2/26
4.Margins & cost structure
%18.1%Q2/26
5.Returns & cash cycle
% · days28.3%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn263Q2/26
8.Funding & debt health
VND bn · times263Q2/26
9.Revenue backlog
VND bn0,91Q2/26
10.Valuation
times · %4,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %696Q2/26
Adjusted EPS growth, latest quarter
82.2%
Average adjusted EPS growth, 3 quarters
191%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26